ABIVAX Company Profile

News Articles [10 Associated News Articles listed on BioPortfolio]

DGAP-News: ABIVAX Eventplan (deutsch)

ABIVAX Eventplan DGAP-News: ABIVAX / Schlagwort(e): Konferenz ABIVAX Eventplan 12.03.2018 / 20:30 Für den Inhalt der Mitteilung ist der Emittent verantwortlich. -----------------------------------...

Abivax believes it has made progress towards HIV cure

Abivax has unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human...Read More... The post Abivax believes it has made progress towards HIV cure app...

ABIVAX Upcoming Events

2017 Financial Results to be announced on March 16, 2018 Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 ABVX), a biotechnology company harnessing the immune system to develop a...

DGAP-News: ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab (deutsch)

ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab DGAP-News: ABIVAX / Schlagwort(e): Studie ABIVAX schließt Patien....

Abivax Completes Enrolment of Phase IIa Clinical Trial of ABX464 to Treat Patients with Ulcerative Colitis

Top-line data in autumn 2018 Ten patients already enrolled in one year open-label extension Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 ABVX), a biotechnology company harnes...

Abivax Ebola antiviral gets financing

Abivax strengthens its management team

Abivax’ shares jump on new Phase IIa HIV data

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

ABIVAX